Lista de obras -

Breast cancer therapy based on melatonin.

artículo científico publicado en 2012

Complementary actions of melatonin on angiogenic factors, the angiopoietin/Tie2 axis and VEGF, in co‑cultures of human endothelial and breast cancer cells

artículo científico publicado en 2017

Editorial for the Special Issue "New Strategies in Cancer Pharmacotherapy: Development of Hormonal Antineoplastic Drugs, Cytotoxic Drugs and Targeted Therapies"

artículo científico publicado en 2020

Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells.

artículo científico publicado en 2007

Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions

artículo científico publicado en 2006

Exposure to light-at-night increases the growth of DMBA-induced mammary adenocarcinomas in rats.

artículo científico publicado en 2005

In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin.

artículo científico publicado en 2010

Infinitesimal Hartman-Grobman Theorem in Dimension Three.

artículo científico publicado en 2015

Melatonin affects the dynamic steady-state equilibrium of estrogen sulfates in human umbilical vein endothelial cells by regulating the balance between estrogen sulfatase and sulfotransferase

scientific article published on 07 October 2015

Melatonin and estradiol effects on food intake, body weight, and leptin in ovariectomized rats.

artículo científico publicado en 2007

Melatonin as a Radio-Sensitizer in Cancer

artículo científico publicado en 2020

Melatonin as a selective estrogen enzyme modulator.

artículo científico publicado en 2008

Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis

artículo científico publicado en 2015

Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF‑7 human breast cancer cells.

artículo científico publicado en 2017

Melatonin enhances the inhibitory effect of aminoglutethimide on aromatase activity in MCF-7 human breast cancer cells.

artículo científico publicado en 2005

Melatonin inhibits angiogenesis in SH-SY5Y human neuroblastoma cells by downregulation of VEGF.

artículo científico publicado en 2017

Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells

artículo científico publicado en 2009

Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium.

artículo científico publicado en 2006

Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity.

artículo científico publicado en 2006

Melatonin modulates aromatase activity and expression in endothelial cells

scientific article published on 28 February 2013

Melatonin modulates the cadmium-induced expression of MT-2 and MT-1 metallothioneins in three lines of human tumor cells (MCF-7, MDA-MB-231 and HeLa).

artículo científico publicado en 2008

Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review).

artículo científico publicado en 2014

Melatonin prevents the estrogenic effects of sub-chronic administration of cadmium on mice mammary glands and uterus.

artículo científico publicado en 2007

Melatonin promotes differentiation of 3T3-L1 fibroblasts.

artículo científico publicado en 2011

Melatonin sensitizes human breast cancer cells to ionizing radiation by downregulating proteins involved in double-strand DNA break repair.

artículo científico publicado en 2015

Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation ⬇️

artículo científico publicado el 16 de abril de 2012

Melatonin-estrogen interactions in breast cancer.

artículo científico publicado en 2005

The effect of estradiol, progesterone, and melatonin on estrous cycling and ovarian aromatase expression in intact female mice

artículo científico publicado en 2013

What is known about melatonin, chemotherapy and altered gene expression in breast cancer

artículo científico publicado en 2017

Lista de obras de

Breast cancer therapy based on melatonin.

Complementary actions of melatonin on angiogenic factors, the angiopoietin/Tie2 axis and VEGF, in co‑cultures of human endothelial and breast cancer cells

Editorial for the Special Issue "New Strategies in Cancer Pharmacotherapy: Development of Hormonal Antineoplastic Drugs, Cytotoxic Drugs and Targeted Therapies"

Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells.

Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions

Exposure to light-at-night increases the growth of DMBA-induced mammary adenocarcinomas in rats.

In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin.

Infinitesimal Hartman-Grobman Theorem in Dimension Three.

Melatonin affects the dynamic steady-state equilibrium of estrogen sulfates in human umbilical vein endothelial cells by regulating the balance between estrogen sulfatase and sulfotransferase

Melatonin and estradiol effects on food intake, body weight, and leptin in ovariectomized rats.

Melatonin as a Radio-Sensitizer in Cancer

Melatonin as a selective estrogen enzyme modulator.

Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis

Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF‑7 human breast cancer cells.

Melatonin enhances the inhibitory effect of aminoglutethimide on aromatase activity in MCF-7 human breast cancer cells.

Melatonin inhibits angiogenesis in SH-SY5Y human neuroblastoma cells by downregulation of VEGF.

Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells

Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium.

Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity.

Melatonin modulates aromatase activity and expression in endothelial cells

Melatonin modulates the cadmium-induced expression of MT-2 and MT-1 metallothioneins in three lines of human tumor cells (MCF-7, MDA-MB-231 and HeLa).

Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review).

Melatonin prevents the estrogenic effects of sub-chronic administration of cadmium on mice mammary glands and uterus.

Melatonin promotes differentiation of 3T3-L1 fibroblasts.

Melatonin sensitizes human breast cancer cells to ionizing radiation by downregulating proteins involved in double-strand DNA break repair.

Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation ⬇️

Melatonin-estrogen interactions in breast cancer.

The effect of estradiol, progesterone, and melatonin on estrous cycling and ovarian aromatase expression in intact female mice

What is known about melatonin, chemotherapy and altered gene expression in breast cancer